Freedman Financial Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-93
| Closed | -$42K | – | 482 |
|
2022
Q1 | $42K | Hold |
93
| – | – | 0.03% | 221 |
|
2021
Q4 | $41K | Sell |
93
-4
| -4% | -$1.76K | 0.03% | 231 |
|
2021
Q3 | $54K | Hold |
97
| – | – | 0.04% | 186 |
|
2021
Q2 | $50K | Sell |
97
-53
| -35% | -$27.3K | 0.04% | 195 |
|
2021
Q1 | $117K | Hold |
150
| – | – | 0.1% | 94 |
|
2020
Q4 | $82K | Buy |
+150
| New | +$82K | 0.07% | 115 |
|